Incyte | INCY - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Agenus USD 71.08M 11.9M 2026-03
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amgen USD 19.52B 1.37B 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Exelixis USD 24.15M 5.47M 2026-03
Gilead Sciences USD 645M 70M 2026-03
Incyte USD 228.62M 1.41B 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
MacroGenics USD 4.29M 500K 2026-03
Merck USD 3.86B 541M 2026-03
Moderna USD 161M 156M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.32B 134M 2026-03
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03